Viewing StudyNCT05033691



Ignite Creation Date: 2024-05-06 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 2:13 PM
Study NCT ID: NCT05033691
Status: RECRUITING
Last Update Posted: 2021-09-05
First Post: 2021-07-04

Brief Title: A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
Sponsor: Hadassah Medical Organization
Organization: Hadassah Medical Organization

Conditions & Keywords Data

Conditions:
Name
Brain Metastases
NSCLC
EGFR Gene Mutation
EGF-R Positive Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Keywords:
Name View
nsclc View
non-small cell lung cancer View
EGFR Gene Mutation View
EGF-R Positive Non-Small Cell Lung Cancer View
EGFR View
Brain Metastases View
osimertinib View
tagrisso View
SRS View
stereotactic radiosurgery View